Key Points Johnson & Johnson has a deep and diversified pharmaceutical portfolio. The company's robotic surgical system, Ottava, could become a meaningful growth driver. Johnson & Johnson has a fantastic dividend track record. 10 stocks we like better than Johnson & Johnson › Johnson & Johnson (NYSE: JNJ) seems to be firing on all cylinders. The company's financial results have been strong this year, leading to a solid stock market performance. Johnson & Johnson's shares aren't too far from their all-time highs right now. However, even at current levels, it's worth investing in the company, at least for investors focused on the long game. Let's consider three reasons why. Image source: The Motley Fool. Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.